XML 107 R95.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplementary Information - Condensed Consolidating Financial Information - Cash Flow (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows From Operating Activities    
Net cash provided by (used in) operating activities $ 9,151 $ 4,596
Cash Flows From Investing Activities    
Capital expenditures and investments (5,133) (3,074)
Working capital changes associated with investing activities (57) (18)
Proceeds from asset dispositions 394 13,740
Net sales (purchases) of short-term investments 996 (2,583)
Long-term advances/loans-related parties 0 0
Collection of advances/loans-related parties 119 115
Intercompany cash management 0 0
Other 16 51
Net Cash Provided by (Used in) Investing Activities (3,665) 8,231
Cash Flows From Financing Activities    
Issuance of debt 0 0
Repayment of debt (4,970) (6,594)
Issuance of company common stock 121 (65)
Repurchase of company common stock (2,073) (2,045)
Dividends paid (1,009) (986)
Other (111) (80)
Net Cash Provided by (Used in) Financing Activities (8,042) (9,770)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash (40) 244
Net Change in Cash and Cash Equivalents and Restricted Cash (2,596) 3,301
Cash and Cash Equivalents and Restricted Cash at beginning of period 6,536 [1] 3,610
Cash and Cash Equivalents and Restricted Cash at end of period 3,940 [2] 6,911
ConocoPhillips - [Member]    
Cash Flows From Operating Activities    
Net cash provided by (used in) operating activities 2,331 (161)
Cash Flows From Investing Activities    
Capital expenditures and investments 0 0
Working capital changes associated with investing activities 0 0
Proceeds from asset dispositions 0 5,000
Net sales (purchases) of short-term investments 0 0
Long-term advances/loans-related parties 0 0
Collection of advances/loans-related parties 0 658
Intercompany cash management 514 2,903
Other 0 0
Net Cash Provided by (Used in) Investing Activities 514 8,561
Cash Flows From Financing Activities    
Issuance of debt 0 0
Repayment of debt 0 (5,459)
Issuance of company common stock 234 87
Repurchase of company common stock (2,073) (2,045)
Dividends paid (1,009) (986)
Other 3 3
Net Cash Provided by (Used in) Financing Activities (2,845) (8,400)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 0 0
Net Change in Cash and Cash Equivalents and Restricted Cash 0 0
Cash and Cash Equivalents and Restricted Cash at beginning of period 0 0
Cash and Cash Equivalents and Restricted Cash at end of period 0 0
Reportable Legal Entities [Member] | ConocoPhillips Company [Member]    
Cash Flows From Operating Activities    
Net cash provided by (used in) operating activities 863 634
Cash Flows From Investing Activities    
Capital expenditures and investments (771) (1,230)
Working capital changes associated with investing activities (77) 36
Proceeds from asset dispositions 307 10,974
Net sales (purchases) of short-term investments 0 0
Long-term advances/loans-related parties (36) (74)
Collection of advances/loans-related parties 3,432 127
Intercompany cash management 3,426 (2,474)
Other 0 0
Net Cash Provided by (Used in) Investing Activities 6,281 7,359
Cash Flows From Financing Activities    
Issuance of debt 10 20
Repayment of debt (4,865) (3,146)
Issuance of company common stock 0 0
Repurchase of company common stock 0 0
Dividends paid 0 0
Other (2,511) (5,000)
Net Cash Provided by (Used in) Financing Activities (7,366) (8,126)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 4 1
Net Change in Cash and Cash Equivalents and Restricted Cash (218) (132)
Cash and Cash Equivalents and Restricted Cash at beginning of period 234 358
Cash and Cash Equivalents and Restricted Cash at end of period 16 226
Reportable Legal Entities [Member] | ConocoPhillips Canada Funding Company I [Member]    
Cash Flows From Operating Activities    
Net cash provided by (used in) operating activities (121) 22
Cash Flows From Investing Activities    
Capital expenditures and investments 0 0
Working capital changes associated with investing activities 0 0
Proceeds from asset dispositions 0 0
Net sales (purchases) of short-term investments 0 0
Long-term advances/loans-related parties 0 0
Collection of advances/loans-related parties 0 0
Intercompany cash management 0 0
Other 0 0
Net Cash Provided by (Used in) Investing Activities 0 0
Cash Flows From Financing Activities    
Issuance of debt 117 0
Repayment of debt 0 0
Issuance of company common stock 0 0
Repurchase of company common stock 0 0
Dividends paid 0 0
Other 0 0
Net Cash Provided by (Used in) Financing Activities 117 0
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 0 0
Net Change in Cash and Cash Equivalents and Restricted Cash (4) 22
Cash and Cash Equivalents and Restricted Cash at beginning of period 4 13
Cash and Cash Equivalents and Restricted Cash at end of period 0 35
Reportable Legal Entities [Member] | All Other Subsidiaries [Member]    
Cash Flows From Operating Activities    
Net cash provided by (used in) operating activities 8,937 6,868
Cash Flows From Investing Activities    
Capital expenditures and investments (4,369) (2,711)
Working capital changes associated with investing activities 20 (54)
Proceeds from asset dispositions 199 12,737
Net sales (purchases) of short-term investments 996 (2,583)
Long-term advances/loans-related parties (127) (20)
Collection of advances/loans-related parties 129 2,196
Intercompany cash management (3,940) (429)
Other 16 51
Net Cash Provided by (Used in) Investing Activities (7,076) 9,187
Cash Flows From Financing Activities    
Issuance of debt 36 74
Repayment of debt (3,547) (855)
Issuance of company common stock 0 0
Repurchase of company common stock 0 0
Dividends paid (452) (2,919)
Other (228) (9,187)
Net Cash Provided by (Used in) Financing Activities (4,191) (12,887)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash (44) 243
Net Change in Cash and Cash Equivalents and Restricted Cash (2,374) 3,411
Cash and Cash Equivalents and Restricted Cash at beginning of period 6,298 3,239
Cash and Cash Equivalents and Restricted Cash at end of period 3,924 6,650
Consolidating Adjustments [Member]    
Cash Flows From Operating Activities    
Net cash provided by (used in) operating activities (2,859) (2,767)
Cash Flows From Investing Activities    
Capital expenditures and investments 7 867
Working capital changes associated with investing activities 0 0
Proceeds from asset dispositions (112) (14,971)
Net sales (purchases) of short-term investments 0 0
Long-term advances/loans-related parties 163 94
Collection of advances/loans-related parties (3,442) (2,866)
Intercompany cash management 0 0
Other 0 0
Net Cash Provided by (Used in) Investing Activities (3,384) (16,876)
Cash Flows From Financing Activities    
Issuance of debt (163) (94)
Repayment of debt 3,442 2,866
Issuance of company common stock (113) (152)
Repurchase of company common stock 0 0
Dividends paid 452 2,919
Other 2,625 14,104
Net Cash Provided by (Used in) Financing Activities 6,243 19,643
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 0 0
Net Change in Cash and Cash Equivalents and Restricted Cash 0 0
Cash and Cash Equivalents and Restricted Cash at beginning of period 0 0
Cash and Cash Equivalents and Restricted Cash at end of period $ 0 $ 0
[1]
*Restated to include $211 million of restricted cash at January 1, 2018. See Note 2—Changes in Accounting Principles for additional information relating to the adoption of ASU No. 2016-18.
[2]
Restricted cash totaling $224 million is included in the "Other assets" line of our Consolidated Balance Sheet as of September 30, 2018.